Surge Care

Decrypting the immune system to drive precision health.

About

Founded

2021

Headquarters

San Francisco, California

Industry

Biotech, Artificial Intelligence (AI)

Company Description

Surge is grounded in more than seven years of clinical, basic science, and translational research led by our team at Stanford University. Our test combines single-cell assessment of the immune system before surgery with clinical data available through Electronic Health Records (EHR) using a proprietary machine learning algorithm. Individual immune systems are comprehensively assessed from a single blood sample obtained before surgery and analyzed using mass cytometry.

Quick Links

WebsiteJobs

Funding

Total Raised

$2.6 million

Valuation

Undisclosed

Significant Investors

Hardware Club, Boutique Venture Partners

Company Traction

  • As of June 2023, Surge Care has two products under development focused on surgical site infection and cognitive decline.

Leadership Team

  • Julien Hédou: Co-Founder & CEO of Surge Care. Former Research Data Analyst at Stanford University School of Medicine.
  • Valentin Picot: COO at Surge Care. Former Legal Counsel at ArcelorMittal France.
  • Benjamin Choisy: Co-Founder & CPO of Surge Care. Former Interne en médecine at Assistance Publique - Hopitaux de Marseille.
  • Franck Verdonk: Chair of the Scientific and Clinical Board at Surge Care. Former Deputy Head of the Anesthesiology and Intensive Care Department at Assistance Publique - Hôpitaux de Paris.
  • Dyani Jones: Member of the Scientific & Clinical Advisory Board at Surge Care. Chief, Section of Dentistry, Clinical Associate Professor, Department of Surgery (Plastic Surgery) at Stanford University.

Press